[Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy; D004338:Drug Combinations; D004952:Esters / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D013451:Sulfonic Acids / Q000627:therapeutic use*; D013806:Theophylline / Q000627:therapeutic use*
D004338:Drug Combinations; D004952:Esters; D009539:Nicotinic Acids; D013451:Sulfonic Acids; D013806:Theophylline
Valoración clínica de un nuevo fármaco "Plasmaclar" en el tratamiento de las hiperlipidemias.